Clinical Trial Update: A Safety Study of Pentamidine in Patients With Metastatic Colon Cancer Undergoing Standard Chemotherapy as Second-line and/or Third-line Treatment [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 safety study evaluating pentamidine in patients with metastatic colorectal cancer undergoing second- or third-line standard chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Pentamidine (pentamidine)

Snippet

Sponsor: Oncozyme Pharma Inc. | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED